Leucovorin Calcium Injection Shortage

• • Leucovorin Calcium injection, Fresenius Kabi, 10 mg/mL, 10 mL vial, 1 count, NDC 63323-0631-10
  • Leucovorin Calcium injection, Fresenius Kabi, 10 mg/mL, 50 mL vial, 1 count, NDC 63323-0631-50
  • Leucovorin Calcium lyophilized powder for solution for injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0711-00
  • Leucovorin Calcium lyophilized powder for injection, Hikma, 50 mg, vial, 1 count, NDC 00143-9555-01
  • Leucovorin Calcium lyophilized powder for solution for injection, Hikma, 350 mg, vial, 1 count, NDC 00143-9552-01
  • Leucovorin Calcium lyophilized powder for injection, Sagent, 100 mg, vial, 10 count, NDC 25021-0814-30
  • Leucovorin Calcium lyophilized powder for injection, Sagent, 200 mg, vial, 1 count, NDC 25021-0815-30
  • Leucovorin Calcium lyophilized powder for injection, Sagent, 500 mg, vial, 1 count, NDC 25021-0828-50

• • Fresenius Kabi had leucovorin on shortage due to manufacturing delays and increased demand.
  • Hikma has leucovorin on shortage due to increased demand.
  • Meitheal has leucovorin on shortage due to increased demand.
  • Sagent has leucovorin on shortage due to increased demand.
  • Teva has discontinued leucovorin injection.
  • Viatris had leucovorin injection available.
  • Slate Run Pharmaceuticals has leucovorin injection available.

• • Leucovorin Calcium, Fresenius Kabi, 200 mg, vial, 1 count, NDC 63323-0710-50
  • Leucovorin Calcium lyophilized powder for injection, Hikma, 100 mg, vial, 1 count, NDC 00143-9554-01
  • Leucovorin Calcium lyophilized powder for injection, Hikma, 200 mg, vial, 1 count, NDC 00143-9553-01
  • Leucovorin Calcium, Meitheal Pharmaceuticals, 100 mg, vial, 1 count, NDC 71288-0161-20
  • Leucovorin Calcium, Meitheal Pharmaceuticals, 200 mg, vial, 1 count, NDC 71288-0162-30
  • Leucovorin Calcium, Meitheal Pharmaceuticals, 350 mg, vial, 1 count, NDC 71288-0163-30
  • Leucovorin Calcium, Meitheal Pharmaceuticals, 50 mg, vial, 1 count, NDC 71288-0160-10
  • Leucovorin Calcium, Meitheal Pharmaceuticals, 500 mg, vial, 1 count, NDC 71288-0164-50
  • Leucovorin Calcium lyophilized powder for injection, Mylan Institutional (Viatris), 200 mg, vial, 1 count, NDC 67457-0529-20
  • Leucovorin Calcium lyophilized powder for injection, Mylan Institutional (Viatris), 350 mg, vial, 1 count, NDC 67457-0530-35
  • Leucovorin Calcium lyophilized powder for injection, Mylan Institutional (Viatris), 50 mg, vial, 1 count, NDC 67457-0528-10
  • Leucovorin Calcium lyophilized powder for injection, Sagent, 350 mg, vial, 1 count, NDC 25021-0816-30
  • Leucovorin Calcium lyophilized powder for solution for injection, Sagent, 50 mg, vial, 10 count, NDC 25021-0813-10
  • Leucovorin Calcium, Slate Run Pharmaceuticals, 100 mg, vial, 1 count, NDC 70436-0117-80
  • Leucovorin Calcium, Slate Run Pharmaceuticals, 200 mg, vial, 1 count, NDC 70436-0118-80
  • Leucovorin Calcium, Slate Run Pharmaceuticals, 50 mg, vial, 10 count, NDC 70436-0116-82
  • Leucovorin Calcium, Slate Run Pharmaceuticals, 500 mg, vial, 1 count, NDC 70436-0119-80

Estimated Resupply Dates

• • Fresenius Kabi has leucovorin 500 mg vials are on back order and the company estimates a release date of mid-December 2024. The 10 mg/mL 10 mL and 50 mL vials are on back order and the company estimates a release date of of mid-March 2025 for the 10 mL vials and mid-February 2025 for the 50 mL vials.
  • Hikma has leucovorin 350 mg vials on allocation. There are short-dated 50 mg vials available with an expiration date of October 2025.
  • Sagent has leucovorin 100 mg vials on a limited allocation. The 200 mg vials are on back order and the company estimates a release date of December 2024. The 500 mg vials are on back order and the company cannot estimate a release date.